A unique opportunity to join a fast-growing organisation working on transformational programmes, backed by the UK government and major cancer charities. This new role will launch and deliver an exciting programme, aimed at accelerating pre-clinical novel therapeutics for brain cancer into human trials with an international world-class panel of experts.

TJBCM is a national convening body delivering transformative national programmes to improve brain tumour research, treatment and care in the UK.
TJBCM designs and currently delivers a national portfolio of eight transformational programmes. We deliver innovative programmes focused on: Accelerating research, building state of the art clinical trial infrastructure, improving care for today’s patients and connecting and training NHS staff through a novel digital platform. The programme is backed by DHSC and several Peers and MPs are part of the leadership team.

The TJBCM has received funding to launch an exciting new programme aimed at accelerating pre-clinical novel therapeutics into human trials, in a faster and more successful way. The programme aims to give scientists direct access to a world-class panel to assess pre-clinical work and help them position their candidate compound towards a realistic pathway to trials.